Luveltamab tazevibulin demonstrated activity in an ongoing phase 2/3 trial of patients with FRα-positive, platinum-resistant ovarian cancer.

Adolescents and young adults have unique needs, and this research highlights financial and social vulnerabilities of young people with cancer,” said Brittany C. Kimball, MD.

Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.

Pediatric patients with ALL experience, on average, about 15 different symptoms in their chemotherapy journey.

Adherence to American Cancer Society guidelines linked to lower mortality in nonsmoking survivors of obesity-related cancer.

For patients and their families during cancer treatment, various resources and temporary housing options aim to ease the ...

A longitudinal assessment of patient-reported outcomes demonstrated that pexidartinib (Turalio) continues to offer clinically meaningful symptom relief with extended use in patients with tenosynovial ...

Enhertu (fam-trastuzumab deruxtecan-nxki) is currently indicated as a second-line therapy for HER2-positive metastatic breast cancer.

Patients who continued to receive pembrolizumab-based therapy after disease progression had longer overall survival than patients who stopped receiving pembrolizumab-based therapy.

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

“AI can enhance clinical decision-making for common acute symptoms in a virtual urgent care setting,” the authors write. “Thoughtful integration of AI into clinical practice, combining its strengths ...

Incorporating the 40-GEP test with BWH staging and NCCN risk group significantly improved risk stratification.